Physician-Patient Alliance for Health and Safety Grants CME Accreditation to First Wave of 2024 World Sepsis Spotlight Courses
CHICAGO, June 11, 2024 (GLOBE NEWSWIRE) -- We are delighted to announce that 4 of the 8 sessions from the World Sepsis Spotlight: Unmet Needs in Sepsis Diagnosis and Treatment, hosted by the Global Sepsis Alliance (GSA) and the Physician-Patient Alliance for Health & Safety (PPAHS) have been accredited by PPAHS for continuing medical education (CME) credits.
Participants can earn continuing medical education credits by viewing the Spotlight sessions here. We are also pleased to confirm that CME credits for the 2024 WSC Spotlight will be issued free of charge.
PPAHS would like to thank Inflammatix, Inc. for their unrestricted educational grant. Inflammatix is a pioneering diagnostics company based in Sunnyvale, California, USA, and is developing innovative diagnostics that rapidly read a patient’s immune system to improve patient care and reduce major public health burdens. Because of generous grants from Inflammatix and others, PPAHS can provide quality clinical educational content.
The remaining 4 sessions will be released on June 25, 2024.
Overview of World Sepsis Spotlight Sessions
The 2024 WSC Spotlight featured sessions by over 40 internationally renowned speakers, panelists, and moderators.
In the 4 sessions now available for CME, they addressed:
The Need for Early Diagnosis and Treatment of Sepsis in Surgical Patients
Data, AI, and Predictive Modeling in Sepsis
How Hypervolemia Increases the Mortality Risk in Sepsis
Detecting Sepsis in Ventilated Patients
The sepsis CME program can now be accessed online, enabling healthcare professionals to complete the first wave of courses at their own schedule and pace. GSA and PPAHS invite healthcare professionals, organizations, and patient advocates to join them in promoting sepsis awareness and improving outcomes for patients worldwide.
About the Physician-Patient Alliance for Health & Safety
The Physician-Patient Alliance for Health & Safety (PPAHS) is ranked internationally as one of the top-100 patient safety organizations worldwide (Agilience Authority Index). As a key national advocate, PPAHS is dedicated to addressing critical health and safety issues shared by patients, physicians, regulators, and the industry alike. By developing and promoting best practices and recommendations, PPAHS significantly advances patient health and safety through the strategic use of information technologies, checklists, and healthcare data. Additionally, the PPAHS serves as a proactive voice in the healthcare community, ensuring that the optimal medications, technology, and medical inventions are employed to improve patient care and reduce costs. Through their collective efforts, the organization cultivates a health ecosystem that fosters a culture of patient safety. For more information about PPAHS, please go to www.ppahs.org.
Media contact:
Michael Wong
Executive Director
admin@ppahs.org
Originally published at GlobeNewswire